T 2524/12 (Anti-ERBB antibody cancer therapy/GENENTECH) of 11.7.2016

European Case Law Identifier: ECLI:EP:BA:2016:T252412.20160711
Date of decision: 11 July 2016
Case number: T 2524/12
Application number: 01939145.7
IPC class: A61K 39/395
A61K 31/335
G01N 33/574
A61P 35/00
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 246 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
Applicant name: Genentech, Inc.
Opponent name: BioGeneriX AG
Teva Pharmaceutical Industries Ltd.
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 113(2)
Keywords: Withdrawal of approval of text on which patent was granted - appeal dismissed
Catchwords:

-

Cited decisions:
T 0163/99
T 1637/06
T 0784/14
Citing decisions:
T 0454/15
T 1021/15

6 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: III Amendments

General Case Law